These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26289221)

  • 1. Prediction of treatment outcomes in major depressive disorder.
    Dunlop BW
    Expert Rev Clin Pharmacol; 2015; 8(6):669-72. PubMed ID: 26289221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging-based biomarkers for treatment selection in major depressive disorder.
    Dunlop BW; Mayberg HS
    Dialogues Clin Neurosci; 2014 Dec; 16(4):479-90. PubMed ID: 25733953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine for long-term depression outcomes using the Personalized Advantage Index approach: cognitive therapy or interpersonal psychotherapy?
    van Bronswijk SC; DeRubeis RJ; Lemmens LHJM; Peeters FPML; Keefe JR; Cohen ZD; Huibers MJH
    Psychol Med; 2021 Jan; 51(2):279-289. PubMed ID: 31753043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker-Guided Tailored Therapy in Major Depression.
    Perna G; Spiti A; Torti T; Daccò S; Caldirola D
    Adv Exp Med Biol; 2024; 1456():379-400. PubMed ID: 39261439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine: Prediction of disease vulnerability in mood disorders.
    Prendes-Alvarez S; Nemeroff CB
    Neurosci Lett; 2018 Mar; 669():10-13. PubMed ID: 27746310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
    Phillips ML; Chase HW; Sheline YI; Etkin A; Almeida JR; Deckersbach T; Trivedi MH
    Am J Psychiatry; 2015 Feb; 172(2):124-38. PubMed ID: 25640931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment decisions based on scalar and functional baseline covariates.
    Ciarleglio A; Petkova E; Ogden RT; Tarpey T
    Biometrics; 2015 Dec; 71(4):884-94. PubMed ID: 26111145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response.
    Olbrich S; Arns M
    Int Rev Psychiatry; 2013 Oct; 25(5):604-18. PubMed ID: 24151805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.
    Craighead WE; Dunlop BW
    Annu Rev Psychol; 2014; 65():267-300. PubMed ID: 24405361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.
    Jaber M; Kahwaji H; Nasr S; Baz R; Kim YK; Fakhoury M
    Adv Exp Med Biol; 2024; 1456():359-378. PubMed ID: 39261438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
    Nemeroff CB
    Am J Psychiatry; 2020 Aug; 177(8):671-685. PubMed ID: 32741287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using neuroimaging to predict treatment response in mood and anxiety disorders.
    Evans KC; Dougherty DD; Pollack MH; Rauch SL
    Ann Clin Psychiatry; 2006; 18(1):33-42. PubMed ID: 16517451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging-aided differential diagnosis of the depressive state.
    Takizawa R; Fukuda M; Kawasaki S; Kasai K; Mimura M; Pu S; Noda T; Niwa S; Okazaki Y;
    Neuroimage; 2014 Jan; 85 Pt 1():498-507. PubMed ID: 23764293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.
    Wallace ML; Frank E; Kraemer HC
    JAMA Psychiatry; 2013 Nov; 70(11):1241-7. PubMed ID: 24048258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine with Omega-3 fatty acids for depression in children and pregnant women and depression associated with inflammation.
    Su KP
    J Clin Psychiatry; 2015 Nov; 76(11):e1476-7. PubMed ID: 26646045
    [No Abstract]   [Full Text] [Related]  

  • 16. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-Guided Tailored Therapy.
    Lydiard J; Nemeroff CB
    Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderators of antidepressant response in major depression.
    Shelton RC; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):e32. PubMed ID: 22075105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does the electroencephalogram tell us about the mechanisms of action of ECT in major depressive disorders?
    Farzan F; Boutros NN; Blumberger DM; Daskalakis ZJ
    J ECT; 2014 Jun; 30(2):98-106. PubMed ID: 24810774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can precision medicine reduce overdiagnosis?
    Hunt S; Jha S
    Acad Radiol; 2015 Aug; 22(8):1040-1. PubMed ID: 26100198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.